Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences: Mark Van Oene, Peter Fromen

Pacific Biosciences announced it has appointed Mark Van Oene to the newly created role of chief operating officer and Peter Fromen as chief commercial officer (CCO), both effective Jan. 8, 2021.

Van Oene joins PacBio after 15 years at Illumina, where he most recently served as senior VP and CCO and oversaw worldwide sales and service. He will be responsible for managing PacBio's research, development, and manufacturing organizations and for driving strategic planning and corporate development activities.

Fromen also joins from Illumina, where he most recently served as global VP of population genomics and precision health. Based in London since 2015, he oversaw Illumina's partnership with Genomics England and the National Health System. Fromen will be responsible for all commercial activity worldwide, including sales, marketing, and customer support.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.